LynxDx Launches Non-invasive Prostate Cancer Screening Solution
LynxDx is introducing a non-invasive, data-driven, urine prostate cancer screening test to guide clinical decisions for patients.
Read MorePosted by Andy Lundin | Feb 10, 2023 | Prostate |
LynxDx is introducing a non-invasive, data-driven, urine prostate cancer screening test to guide clinical decisions for patients.
Read MorePosted by Andy Lundin | Feb 8, 2023 | Sexually Transmitted Diseases |
Thermo Fisher Scientific launched a PCR test designed to detect several STIs, as well as RNase P, included as a human internal control.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Leukemia |
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Diagnostic Technologies, Disease States |
A new saliva-based test that can predict the risk of developing different kinds of cancers and other serious diseases is now available.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Kidney Disease |
Natera detailed a paper highlighting the clinical utility of its comprehensive kidney gene panel Renasight in aiding kidney disease diagnosis.
Read More